Charcot-Marie-Tooth disease is a genetic condition that affects the peripheral nerves in the legs, feet, and hands. People with Charcot-Marie-Tooth disease often notice foot drop, ankle weakness, numbness, and balance problems, and doctors may see high arches or hammertoes. Symptoms usually begin in childhood or early adulthood and tend to progress slowly over many years. Most people with Charcot-Marie-Tooth disease have a normal life span, though severity varies. Treatment focuses on support with physical therapy, ankle–foot orthoses, pain control, and sometimes surgery for foot deformities.
Overview
Charcot-marie-tooth diseaseSymptoms
Charcot-Marie-Tooth disease causes slowly worsening nerve problems, usually starting in the feet and legs. Early symptoms may include ankle weakness, tripping, foot drop, high arches, and numbness or tingling. Hands can become weak over time.
Outlook and prognosis
Many living with Charcot-Marie-Tooth disease stay active for decades, though symptoms often progress slowly. Most people retain walking ability with supports, tailored therapy, and pain management. Early attention to foot care, balance, and energy conservation helps maintain independence and quality of life.
Causes and risk factors
Charcot‑Marie‑Tooth disease mostly stems from inherited gene changes, though new (de novo) mutations occur. Risk rises with a family history; inheritance may be autosomal dominant, recessive, or X‑linked. Diabetes and certain neurotoxic drugs can aggravate symptoms.
Genetic influences
Genetics is central to Charcot-Marie-Tooth disease; most cases are inherited changes in specific genes affecting peripheral nerves. Different gene variants can influence age at onset, severity, and which nerves are involved. Genetic testing helps confirm diagnosis and guide family planning.
Diagnosis
Doctors diagnose Charcot-Marie-Tooth disease based on clinical features, family history, and a neurologic exam. Nerve conduction studies and electromyography confirm peripheral nerve involvement. Genetic tests can pinpoint the type; genetic diagnosis of Charcot-Marie-Tooth disease guides counseling and family testing.
Treatment and drugs
Treatment for Charcot‑Marie‑Tooth disease focuses on staying mobile, comfortable, and independent. Many benefit from physical and occupational therapy, custom braces or splints, protective footwear, and pain control; selected cases use surgery for troublesome deformities. Genetic counseling and regular neurologic and foot care help plan ahead.
Symptoms
Walking on uneven ground, keeping your balance in the shower, or buttoning a shirt can start to take more effort. Charcot-Marie-Tooth disease is a hereditary nerve condition that mainly affects the feet and hands, so changes often show up first at the edges of movement and touch. Early features of Charcot-Marie-Tooth disease often include foot or ankle weakness, frequent tripping, or high arches, with hand changes appearing later. Features vary from person to person and can change over time.
The front of the foot doesn’t lift well while walking, so toes can catch the ground. This often leads to a high-stepping walk and more trips. Foot drop is common in Charcot-Marie-Tooth disease.
The curve of the foot becomes high and toes can curl. Shoes may feel tight across the top and painful pressure spots can form. High arches are a classic sign in Charcot-Marie-Tooth disease.
Weakness around the ankle can let the foot roll outward. Repeated twists or sprains are common, especially on uneven surfaces.
Staying steady can be harder, especially in the dark or when you can’t watch your steps. Less awareness of where your feet are makes stumbles and falls more likely.
How people usually first notice Charcot-marie-tooth disease?
Many people first notice Charcot-Marie-Tooth disease when everyday movements start to feel awkward: frequent tripping, ankles that roll easily, or shoes wearing down at the outer edges from a high-arched foot. Hand tasks can become trickier too, like fastening buttons or opening jars, and cramps or tingling in the feet and lower legs may show up after mild activity. These first signs of Charcot-Marie-Tooth disease often appear in the teens or early adulthood but can show earlier or later, prompting a check-up when weakness, balance changes, or foot shape differences are hard to ignore.
Types of Charcot-marie-tooth disease
Charcot-Marie-Tooth disease has several well-recognized clinical variants. These types are usually defined by the gene involved and whether the nerve’s insulation (myelin) or the inner wire (axon) is mainly affected, which can change the age at onset, speed of nerve signals, and symptom severity. Clinicians often describe them in these categories: demyelinating (CMT1), axonal (CMT2), intermediate forms, X-linked, recessive/early-onset forms, and rarer dominant or recessive subtypes. Not everyone will experience every type.
CMT1 (demyelinating)
This common type primarily affects the myelin around peripheral nerves, slowing nerve conduction on tests. People often develop foot deformities, ankle weakness, and sensory loss starting in childhood or the teen years.
CMT2 (axonal)
Here the inner part of the nerve fiber is mainly affected, so conduction speed may be closer to normal but signal strength is reduced. Symptoms may start later, sometimes in adulthood, and often involve distal weakness, numbness, and balance problems.
Intermediate CMT
Nerve tests show features between demyelinating and axonal patterns. Symptoms vary but can include childhood-to-adult onset of foot drop, hand weakness, and reduced sensation.
CMTX (X-linked)
Caused by changes in a gene on the X chromosome, this type is often more severe in males than females. Onset is usually in childhood or adolescence, with leg and hand weakness and sometimes brisk reflexes; females may have milder signs.
Autosomal recessive (CMT4)
These forms are less common, often begin in childhood, and can be more severe. People may have earlier walking difficulties, scoliosis, and pronounced foot deformities.
Dominant intermediate forms
Some genes cause a mixed nerve pattern with dominant inheritance. Age at onset and severity can vary widely, from mild adult-onset weakness to earlier, more noticeable symptoms.
Dejerine–Sottas disease
A severe early-onset demyelinating variant, typically presenting in infancy or early childhood. Children may have delayed motor milestones, low muscle tone, and rapidly progressive weakness.
Hereditary neuropathy with liability to pressure palsies: A related subtype where nerves are unusually sensitive to pressure or stretch. People may have recurrent episodes of numbness or weakness after minor compression, with recovery over weeks to months; between episodes, symptoms can be mild.
Gene-specific subtypes
Variants linked to specific genes (like PMP22 duplication, MPZ, GJB1, MFN2) have recognizable patterns. For many, this can mean earlier or later onset, different rates of progression, or added features such as tremor or vision-related nerve involvement; types of Charcot-Marie-Tooth disease are often defined this way.
What genetics can tell you about symptoms
Certain CMT1A variants involving PMP22 cause slowly progressive foot weakness, high arches, and numbness as the myelin “insulation” around nerves thins. CMT2 forms tied to MFN2 or GJB1 more often bring burning pain, balance troubles, and earlier hand weakness from direct nerve-fiber damage.
Causes and risk factors
Charcot-Marie-Tooth disease is caused by changes in genes that help peripheral nerves work.
Doctors distinguish between risk factors you can change and those you can’t.
Most people inherit the gene change from a parent, but some have a new change with no family history.
The chance and timing of early symptoms of Charcot-Marie-Tooth disease can depend on the specific gene and the way it is passed down, such as dominant, recessive, or X‑linked.
Some exposures do not cause the disease but can make symptoms worse, including certain chemotherapy drugs like vincristine, heavy alcohol use, and poorly controlled diabetes.
Environmental and biological risk factors
Charcot-marie-tooth disease (CMT) is typically present from birth and does not arise from everyday exposures. Researchers have not identified environmental risk factors for Charcot-marie-tooth disease that reliably increase the chance of being born with it. Doctors often group risks into internal (biological) and external (environmental). Here’s what current evidence shows about these factors and CMT.
No clear evidence older maternal or paternal age raises the chance of having a child with this condition. Current research in peripheral nerve disorders has not shown a consistent link.
Maternal diabetes, thyroid disease, or high blood pressure are not known to increase the likelihood of Charcot-marie-tooth disease. These conditions can affect pregnancy in other ways, but they are not considered causes.
Exposure during pregnancy to radiation, heavy metals, or hormone-disrupting chemicals has no confirmed association with a baby being born with Charcot-marie-tooth disease. Available studies have not identified a causal link.
Prematurity, low birth weight, or delivery complications do not cause Charcot-marie-tooth disease. Events during labor are not known to trigger the underlying nerve changes.
Genetic risk factors
For Charcot-Marie-Tooth disease, changes in a number of genes that guide how peripheral nerves are built and maintained are the main driver, either inherited or appearing for the first time. The specific gene and inheritance pattern can shape age at onset, severity, and early symptoms of Charcot-Marie-Tooth disease. Family history is the strongest clue, but genetic testing usually confirms the subtype. Carrying a genetic change doesn’t guarantee the condition will appear.
Family history: Having close relatives with Charcot-Marie-Tooth disease raises the chance of inheriting the same genetic change. Patterns seen across generations can hint at the subtype. Genetic counseling can help map who else may be at risk.
Autosomal dominant: A single changed copy of a CMT gene from one parent can cause the condition. Each child of an affected parent has a 50% chance to inherit that change. Severity can differ between relatives.
Autosomal recessive: Two changed copies of a CMT gene—one from each parent—are needed to cause disease. Parents are usually healthy carriers. Risk is higher when both partners carry the same gene change.
X-linked inheritance: Changes in the GJB1 gene on the X chromosome can cause X-linked Charcot-Marie-Tooth disease. Males tend to be more affected, while females may have milder or later symptoms. Family trees often show affected males linked through mothers.
New mutations: Sometimes a genetic change causing CMT appears for the first time in a child, with no prior family history. The child can still pass it to future children. Testing parents can confirm whether it is new.
PMP22 duplication: Extra copies of the PMP22 gene cause CMT1A, the most common form worldwide. This change affects the myelin coating on nerves, slowing signals to the feet and hands. Many families with CMT have this specific duplication.
MPZ variants: Changes in the MPZ gene can cause CMT1B and related types. These affect the myelin structure, with symptoms ranging from childhood onset to later-life weakness or numbness. Even within a family, timing and severity can vary.
MFN2 variants: MFN2 gene changes are a leading cause of axonal CMT (CMT2A). They disrupt the nerve fiber itself and may start in childhood or the teen years. Some variants are linked to more rapid progression.
GJB1 variants: Variants in the GJB1 gene cause CMTX1, an X-linked form of Charcot-Marie-Tooth disease. Nerve communication across myelin layers is altered, leading to weakness and sensory loss. Females who carry the change may have variable symptoms.
Other rare genes: Dozens of additional genes can cause Charcot-Marie-Tooth disease, including GDAP1, SH3TC2, and HSPB1. These are less common overall but may be more frequent in certain regions or communities. A comprehensive panel test often finds the cause.
Founder effects: In some populations, a historical founder change makes a specific CMT gene variant more common. This can increase the chance two carriers meet and have an affected child. Your clinician may tailor testing based on ancestry.
Myelin or axon: Genes that affect the myelin sheath tend to slow nerve signaling, while genes that affect the nerve fiber itself reduce signal strength. Knowing which pathway is involved helps guide which genes to test first. It also helps explain patterns seen on nerve studies.
Variable expression: The same genetic change can lead to different ages of onset and severity among relatives. People with Charcot-Marie-Tooth disease in one family may have mild symptoms while others need braces or mobility aids. People with the same risk factor can have very different experiences.
Lifestyle risk factors
Charcot-Marie-Tooth disease is inherited; lifestyle habits do not cause it but can influence function, symptoms, and complications over time. Understanding how lifestyle affects Charcot-Marie-Tooth disease can help you protect mobility, reduce pain, and lower injury risk. Below are practical lifestyle risk factors for Charcot-Marie-Tooth disease and how to manage them effectively.
Regular low-impact movement helps maintain muscle strength and joint range in weakened ankles and feet. Overexertion or high-impact sports can increase sprains and falls when ankles are unstable.
Targeted strengthening of dorsiflexors, hip muscles, and core can improve gait and reduce tripping. Skipping balance training may raise fall risk in Charcot-Marie-Tooth disease.
Excess body weight adds stress to weak ankles and arches, worsening pain and fatigue. Gradual weight loss can ease walking and lower the risk of joint strain and falls.
Supportive shoes and ankle-foot orthoses can improve foot drop, reduce tripping, and prevent calluses. Unsupportive or ill-fitting shoes can worsen instability and pressure points.
Risk prevention
Charcot-Marie-Tooth disease (CMT) is inherited, so you can’t fully prevent it, but you can lower the risk of complications and protect function over time. Prevention is about lowering risk, not eliminating it completely. The focus is on joint and nerve protection, safer movement, and foot health to maintain mobility and independence. Getting help early—especially if you notice early symptoms of Charcot-Marie-Tooth like ankle weakness or frequent tripping—can make everyday life easier.
Learn your family’s CMT pattern and chances of passing it on. Discuss options like carrier testing, prenatal testing, or IVF with embryo testing.
Gentle, tailored exercises keep joints flexible and muscles as strong as possible. A physical therapist can teach safe stretching to slow contractures and reduce falls.
Braces and supportive shoes can steady weak ankles and improve walking. Orthotics help prevent falls and reduce strain that can worsen CMT symptoms.
Daily checks can catch blisters, calluses, or pressure spots early. Prompt podiatry care helps prevent ulcers and infections when sensation is reduced in CMT.
Transmission
Charcot-Marie-Tooth disease (CMT) is not contagious—you can’t catch it from contact, coughs, or shared items. Most people develop CMT because they inherit a change in a nerve-related gene from a parent; this is the genetic transmission of Charcot-Marie-Tooth disease.
How Charcot-Marie-Tooth disease is inherited varies: it can be autosomal dominant (one altered copy is enough—each child has a 50% chance), autosomal recessive (both parents carry the change—there’s a 25% chance in each pregnancy), or X‑linked (often passed through mothers, with sons more likely to be affected). Some people are the first in their family with CMT due to a new mutation, and severity can differ even among relatives. A genetics professional can review your family pattern and discuss your child’s chances.
When to test your genes
Consider genetic testing if you have progressive numbness or weakness in your feet or hands, a high-arched foot, foot drops, or a strong family history of similar symptoms. Testing helps confirm Charcot-Marie-Tooth subtype, guide prognosis, tailor therapy, and inform relatives’ risks. It’s also useful before family planning or when symptoms begin early.
Diagnosis
For many, early clues are tripping, frequent ankle sprains, high arches, or hand weakness that makes buttons harder. Diagnosis often starts with recognizable patterns on exam and family history, then specific tests to confirm what’s suspected. Doctors usually begin with a focused nerve and muscle exam and then confirm the genetic diagnosis of Charcot-Marie-Tooth disease with targeted DNA testing. Early and accurate diagnosis can help you plan ahead with confidence.
Providers look for weakness in the lower legs and hands, muscle thinning around the calves, high arches or curled toes, and reduced ankle reflexes. This pattern of clinical features points toward Charcot-marie-tooth disease and helps rule out other nerve problems.
A simple family tree can show whether similar symptoms occurred in relatives and how they were passed down. Family history is often a key part of the diagnostic conversation and can guide which genetic tests to order.
Small electrodes measure how fast and how strongly signals travel along the nerves. Slowed speeds or smaller signal sizes support a peripheral neuropathy and help classify the type of Charcot-marie-tooth disease.
A fine needle records how muscles respond to nerve signals. EMG helps confirm that weakness comes from nerve damage rather than a muscle disorder.
Stages of Charcot-marie-tooth disease
Charcot-marie-tooth disease does not have defined progression stages. It tends to change slowly over many years and can vary widely by genetic subtype and even within the same family, with stretches where symptoms feel fairly stable. Different tests may be suggested to help confirm the diagnosis and map how the nerves are working. If you’re noticing early symptoms of Charcot-marie-tooth disease—like frequent ankle rolls, foot drop, or trouble keeping up—a neurological exam and, in many cases, genetic testing can guide care and long-term follow-up.
Outlook and prognosis
Daily routines often adapt as Charcot-Marie-Tooth disease (CMT) changes strength and balance over time—maybe choosing shoes with better grip, taking the lift on days when stairs feel shaky, or using a brace to keep a steady gait. The outlook is not the same for everyone, but many people with CMT have a normal life span and remain active in work, family life, and hobbies. Weakness and numbness typically progress slowly, most often starting in the feet and lower legs before involving the hands. Falls, foot deformities, and fatigue can accumulate, yet good foot care, physical therapy, and assistive devices often help people stay mobile and independent.
Understanding the prognosis can guide planning and set realistic goals for the years ahead. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, so the specific CMT subtype and your day-to-day routines both matter. Early symptoms of Charcot-Marie-Tooth disease may be mild, and some people notice gradual changes only over decades; others experience faster progression or earlier hand involvement. Severe breathing or swallowing issues are uncommon but can occur in certain rare subtypes; when present, they raise health risks and warrant specialist care. While CMT itself usually does not shorten life, complications like serious falls, fractures, or pressure injuries can affect health if not addressed early.
With ongoing care, many people maintain independence, adapt activities, and plan confidently for the future. Consider periodic visits with neuromuscular specialists and physical therapists, ankle-foot orthoses when needed, and proactive fall-prevention at home. Genetic testing can sometimes provide more insight into prognosis, especially if you’re weighing family planning or clinical trial options. Talk with your doctor about what your personal outlook might look like, including how to monitor changes and when to adjust your care plan.
Long-term effects
Charcot-Marie-Tooth disease tends to progress slowly over many years, most often affecting the feet and hands first. Long-term effects vary widely, and the pace of change can be quite different from one person to another. Many people live a typical lifespan, though day-to-day function may change over time. Some notice early symptoms of Charcot-Marie-Tooth disease in the teenage years, while others don’t feel changes until adulthood.
Weakness usually starts in the lower legs and feet, then may involve the hands and forearms. Over time, this can make climbing stairs, opening jars, or typing more difficult. Progression is generally slow.
High arches, hammertoes, and a narrow foot shape can become more pronounced with time. These changes can make shoes uncomfortable and walking less stable. They may lead to calluses or pressure spots.
Nerve changes can reduce ankle stability and sensation, making uneven ground tricky. Many experience frequent ankle sprains or occasional falls. Extra caution may be needed in the dark or on stairs.
Numbness or reduced feeling in the feet and hands can slowly increase. This may make it hard to sense blisters, temperature, or small injuries. Some also notice tingling or burning sensations.
How is it to live with Charcot-marie-tooth disease?
Living with Charcot-Marie-Tooth disease often means planning your day around energy and balance—picking shoes with good support, taking breaks to prevent fatigue, and using braces or mobility aids when needed to stay steady and safe. Fine motor tasks like buttoning, typing for long stretches, or opening jars can be frustrating, and cramps or burning sensations in the feet may flare after activity or at night. Many lean on physical and occupational therapy to keep strength and flexibility, and they adapt home and work spaces to reduce falls and conserve energy. For family and friends, it’s a shift toward patience and practical help—slower walks, shared problem-solving, and encouragement—while remembering that many people with Charcot-Marie-Tooth lead full, independent lives with the right supports.
Treatment and drugs
Treatment for Charcot-Marie-Tooth disease focuses on easing symptoms, protecting joint and nerve function, and supporting mobility over time. Physical and occupational therapy are core parts of care, using stretching, balance, and strengthening to maintain flexibility and reduce falls; braces, custom shoes, and splints can steady ankles, improve walking, and help with hand tasks. Pain is managed with medicines for nerve pain (such as certain antidepressants or anti-seizure drugs), anti-inflammatories for joint or muscle aches, and careful foot care to prevent wounds and infections; a doctor may adjust your dose to balance benefits and side effects. Surgery may be considered for severe foot deformities or tendon problems that limit walking, while speech or breathing support is rarely needed but can help if throat or respiratory muscles are involved. Alongside medical treatment, lifestyle choices play a role: regular low‑impact exercise, fall‑prevention at home, smoking cessation, and checking feet daily, plus genetic counseling and periodic follow-up to update your plan as needs change.
Non-drug treatment
Charcot-Marie-Tooth disease affects how nerves talk to muscles, so daily movement, balance, and hand tasks can become harder over time. Many people notice tripping on flat ground, ankle rolling, hand fatigue with buttons, or sore feet after short walks. Non-drug treatments often lay the foundation for staying active, steady, and independent. A tailored plan, updated as needs change, usually works best.
Targeted exercises help keep muscles working and joints moving well. A therapist can tailor strengthening and gentle range-of-motion work to your goals.
Training and tools can make dressing, writing, and kitchen tasks easier. Therapists suggest practical tweaks to reduce hand fatigue and save energy.
Lightweight ankle-foot braces can lift the toes and steady weak ankles. Recognizing early symptoms of Charcot-Marie-Tooth disease can guide timely bracing to reduce trips and falls.
Supportive shoes and inserts spread pressure and improve stability. A good fit helps protect the skin and reduce pain from high arches or hammertoes.
Your genes may have an impact on how drugs work for you
Medicines for Charcot‑Marie‑Tooth disease can work differently from person to person because gene changes affect nerve biology, drug processing, and side‑effect risk. Genetic testing and careful dosing help clinicians choose safer options and avoid drugs that may worsen nerve damage.
Pharmacological treatments
Medicines for Charcot-Marie-Tooth disease focus on easing nerve pain, muscle cramps, and tremor so daily tasks feel more manageable. Drugs that target symptoms directly are called symptomatic treatments. While no approved drug slows or reverses CMT yet, several well-studied options can improve comfort and function. These medicines may be used when early symptoms of Charcot-Marie-Tooth disease begin to affect work, sleep, or walking.
These calm overactive pain signals and often ease burning, tingling, or shooting nerve pain. Dosing may be increased or lowered gradually to balance pain relief with side effects.
These antidepressant‑class medicines also treat nerve pain in CMT. They may help if pain and low mood travel together, though nausea or sweating can occur.
Low evening doses can improve neuropathic pain and help sleep. Dry mouth and constipation are common, and heart rhythm checks may be needed in some people.
Patches or gels can numb a painful spot in the foot or ankle. This targets pain locally with fewer whole‑body side effects.
Genetic influences
In most people, Charcot-Marie-Tooth disease is inherited, with a gene change that can be passed through a family. Many different genes can lead to CMT, and inheritance can look different from family to family: one affected parent may pass it on (dominant), two symptom-free carriers may have an affected child (recessive), or it may be linked to the X chromosome. Sometimes a new change arises for the first time in a child, so there’s no prior family history. Relatives who share the same genetic cause can still have very different ages of onset and levels of weakness or numbness. DNA testing can sometimes identify these changes. Results from genetic testing for Charcot-Marie-Tooth disease can confirm the subtype, shape follow-up care, and inform family planning; many people work with a genetic counselor to understand options for themselves and their relatives.
Is Charcot-marie-tooth disease genetic?
Genetics is central to Charcot-Marie-Tooth disease; most cases are inherited changes in specific genes affecting peripheral nerves. Different gene variants can influence age at onset, severity, and which nerves are involved. Genetic testing helps confirm diagnosis and guide family planning.
Pharmacogenetics—how genetics influence drug effects
In people with Charcot-Marie-Tooth disease, the specific gene change and subtype can shape which treatments are safest, guide eligibility for clinical trials, and influence how to use common pain medicines. Some chemotherapy drugs and other nerve‑toxic medicines can sharply worsen neuropathy in certain forms—vincristine is a well‑known example doctors avoid in many with CMT1A—so teams often choose alternatives. With this in mind, doctors tailor medication plans and dosing to the CMT subtype and watch closely for side effects. Genetic testing can sometimes identify how your body processes certain pain medicines, which can guide dosing or point to a different option if relief is limited. This pharmacogenetic approach is especially relevant for drugs like some antidepressants, anti‑seizure medications, and opioids that are often used for nerve pain in Charcot-Marie-Tooth disease. Differences in response aren’t only genetic; age, kidney and liver health, other medications, and the degree of nerve damage also play a role, so treatments for Charcot-Marie-Tooth disease are individualized and revisited over time.
Interactions with other conditions
Living with Charcot-Marie-Tooth disease alongside other health conditions can change how symptoms feel day to day. When diabetes is also present, the extra strain on nerves can speed up numbness, burning pain, and balance problems, raising the risk of foot ulcers and falls if foot care is not stepped up. A condition may “exacerbate” (make worse) symptoms of another, so low thyroid function, kidney disease, or severe vitamin B12 deficiency can deepen fatigue, cramps, or tingling and make walking harder. Autoimmune nerve inflammation, such as chronic inflammatory neuropathy, can overlap with inherited neuropathy and sometimes causes a sudden or stepwise downturn; sorting this out matters because the inflammatory part may respond to treatment. People with sleep apnea or obesity may notice more daytime tiredness and weaker endurance, which can mask early symptoms of Charcot-Marie-Tooth disease or make them seem to progress faster. Interactions can look very different from person to person, so coordinated care and regular reviews help tailor support when more than one condition is in the mix.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which several relatives had high arches, ankles that turned easily, and legs that tired after short walks. In one family story, a grandparent wore sturdy boots year-round to “steady the ankles,” while a grandchild later needed braces for foot drop during school sports. These everyday details echo what doctors would eventually recognize as Charcot–Marie–Tooth disease.
First described in the medical literature as a pattern of slowly progressive weakness and wasting in the lower legs and feet, Charcot–Marie–Tooth disease (often shortened to CMT) was named after three physicians who published detailed reports in the late 1800s. Initially understood only through symptoms, later examinations of nerves under the microscope showed that in some people the insulating layer around nerves was thin or damaged, while in others the nerve fibers themselves were reduced. Over time, descriptions became clearer as doctors realized the hands could also be affected, and that balance problems and numbness were common features.
Families and communities once noticed patterns that hinted at inheritance long before genetic tests existed. Some branches saw the condition pass from parent to child in many generations, while others noticed it skipped a generation or appeared only in siblings. These observations helped shape the idea that CMT was not one single condition, but a group of related nerve disorders with different inheritance paths.
As medical science evolved, nerve conduction studies in the mid-20th century allowed clinicians to measure how fast electrical signals traveled along nerves. This split CMT into forms with slow signal speed, suggesting damage to the nerve’s covering, and forms with relatively normal speed but weaker signals, pointing to loss of nerve fibers. This practical testing improved diagnosis and helped families understand what to expect.
Advances in genetics in the late 20th and early 21st centuries identified specific gene changes responsible for many types of Charcot–Marie–Tooth disease. Researchers found that some genes act like dimmer switches for the proteins that build and maintain peripheral nerves; when they are turned too low or too high, signals to the muscles of the feet and hands weaken over time. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, awareness has grown that CMT is more common than once thought and varies widely, even within the same family. Modern care focuses on early recognition of early symptoms of Charcot–Marie–Tooth disease—such as frequent ankle sprains, tripping, or trouble with fine finger tasks—so that supportive therapies, braces, and tailored exercise can help people stay active. Knowing the condition’s history shows how everyday observations, careful examination, and genetic discoveries came together to shape current care.